TBPH compared with CAN: revenue, margins and what each company keeps, and the suppliers and customers both name

TBPHTheravance Biopharma, Inc.

Mkt capRevenueRevenue

CANCanaan Inc.

Mkt capRevenueRevenue

Compare

TBPHTheravance Biopharma, Inc.

CANCanaan Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TBPH 6

VTRSViatrissupplier

LAZLazardsupplier

GSKGSKcustomer

RPRXRoyalty Pharma Investmentscustomer

2 more · TBPH chain ›

Shared 0

No disclosed counterparties: CAN.

Only CAN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

TBPHTheravance Biopharma, Inc.

17.03· pre 17.04· delayed

Mkt cap$884.2MRevenue$21MQ2 FY26Revenue$107MFY25

CANCanaan Inc.

0.20· pre 0.20· delayed

Pre-marketNov 3 '26delayed

Mkt cap$139.7MRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

TBPHTheravance Biopharma, Inc.

CANCanaan Inc.

17.03pre 17.04delayed

Price

0.20pre 0.20delayed

$884.2M

Mkt cap

$139.7M

Q2 FY26$21M

Revenue

—

FY25$107M

Revenue

—

TBPH17.03vsCAN0.20Pre-marketNov 3 '26delayed